Jorge Plutzky, M.D. is the Director of Preventive Cardiology, which includes the Lipid/Prevention Clinic, for the Cardiovascular Division at Brigham and Women’s Hospital (BWH), and is on the faculty of Harvard Medical School. Dr. Plutzky is a nationally and internationally recognized expert in preventive cardiology and lipid disorders. He has been especially recognized for his role in helping understand links between cardiovascular disease and metabolic problems like obesity, dyslipidemia and diabetes. He also directs a basic science laboratory that studies transcriptional mechanisms connecting these issues. Clinically, he is involved in many programs that seek to address cardiometabolic both clinically and in regards to clinical translational research projects. In these settings, he often deals with complex inherited lipid and cholesterol disorders. Dr. Plutzky was the first cardiologist to serve on the Food and Drug Administration’s Endocrine and Metabolic Advisory Committee and remains involved with the FDA on multiple levels. Dr. Plutzky and his laboratory have received many awards, including the American Heart Association’s Katz Basic Science Prize, the University of Cologne’s Klenck Award, Harvard Medical School’s Tucker Collins Lectureship and the Braunwald Teaching Award. Dr. Plutzky received his Bachelor of Arts degree from the University of Virginia, where he was an Echol’s Scholar and graduated “With Highest Honors”, and his M.D. from the University of North Carolina School of Medicine. Internship, residency in internal medicine, and cardiology fellowship were all completed at Brigham and Women’s Hospital/Harvard Medical School in Boston, during which time he also completed a post-doctoral fellowship at the Massachusetts Institute of Technology. He is actively involved with the American Heart Association and the American College of Cardiology and has been elected to the American Society for Clinical Investigation.